vaccine

TWiV 165: The email zone

Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, and Alan Dove Vincent, Dickson, Rich, and Alan answer listener questions about XMRV, cytomegalovirus, latency, shingles vaccine, myxomavirus and rabbits, and more. Please help us by taking our listener survey. Click the arrow above to play, or right-click to download TWiV 165 (61 MB .mp3, 102 minutes). Subscribe to TWiV …

TWiV 165: The email zone Read More »

A $707 million investment in cell-based influenza vaccine

The United States has provided a large sum of money to pharmaceutical giant Novartis to produce influenza vaccines grown in cell culture. According to CIDRAP: Novartis’s US efforts have been spurred by two major federal contracts. In 2006 the firm won a $220 million HHS contract to develop cell-based flu vaccines, and in January 2009 …

A $707 million investment in cell-based influenza vaccine Read More »

TWiP 31: A malaria vaccine

Hosts: Vincent Racaniello and Dickson Despommier Vincent and Dickson discuss the promising results of a phase III trial of a malaria vaccine in African children. [powerpress url=”http://traffic.libsyn.com/twip/TWiP031.mp3″] Click the arrow above to play, or right-click to download TWiP #31 (50 MB .mp3, 70 minutes). Links for this episode: First results of RTS,S/AS01 phase III trial (NEJM) Development …

TWiP 31: A malaria vaccine Read More »

TWiV 150: Contaminated

Hosts: Vincent Racaniello, Rich Condit, and Dickson Despommier Vincent, Dickson, and Rich meant to do an all-email episode, but first they review results of the Blood XMRV Scientific Research Working Group, and partial retraction of the paper associating XMRV with chronic fatigue syndrome. With this episode TWiV is three years old. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV150.mp3″] Click the arrow above …

TWiV 150: Contaminated Read More »

Scroll to Top